Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PGR vs GSK✓SelectedUSD · GSKPGR vs GSK performance historyLatest closeAs of+0.62%11/20
Stock and ETF performance explorer

PGR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+180.8%
GSK return
+40.7%
Excess return
+140.1%
Maximum drawdown
-30.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.6%-0.1%+0.7%+0.6%
7D-1.9%-5.3%+3.5%-0.9%
30D+4.5%-3.7%+8.2%+5.2%
3M+5.1%-7.3%+12.3%+6.4%
6M+14.3%-4.2%+18.6%+15.0%
YTD+8.2%+0.9%+7.4%+7.3%
1Y+9.0%+7.3%+1.8%+6.9%
3Y+58.8%+52.7%+6.1%+43.4%
All+180.8%+40.7%+140.1%+146.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling